High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,640,256
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TXG |
10x Genomics, Inc.
|
CEO
10b5-1 Sell
|
2026-03-02 | $43,111 | S | Form 4 |
| TXG |
10x Genomics, Inc.
|
CEO
10b5-1 Sell
|
2026-03-02 | $323,985 | S | Form 4 |
| TXG |
10x Genomics, Inc.
|
Director
10b5-1 SellΔOwn -22.1%
|
2026-02-25 | $147,108 | S | Form 4 |
| TXG |
10x Genomics, Inc.
|
CFO
Sell to Cover
|
2026-02-23 | $166,593 | S | Form 4 |
|
TXG
S
10x Genomics, Inc.
Hindson Benjamin J.
• Officer • See Remarks
Sell to Cover
2026-02-23
$145,379
|
||||||
| TXG |
10x Genomics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-23 | $145,379 | S | Form 4 |
| TXG |
10x Genomics, Inc.
|
CEO
Sell to Cover
|
2026-02-23 | $178,928 | S | Form 4 |
| TXG |
10x Genomics, Inc.
|
CEO
Sell to Cover
|
2025-11-24 | $251,936 | S | Form 4 |
| TXG |
10x Genomics, Inc.
|
CFO
Sell to Cover
|
2025-11-24 | $225,852 | S | Form 4 |
|
TXG
S
10x Genomics, Inc.
Hindson Benjamin J.
• Officer • See Remarks
Sell to Cover
2025-11-24
$157,363
|
||||||
| TXG |
10x Genomics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-24 | $157,363 | S | Form 4 |